BEIJING: China has approved three Covid-19 vaccine candidates for clinical trials, said an official with the Ministry of Science and Technology (MOST).
An adenovirus vector vaccine, developed by a research team led by Chen Wei, an academician with the Chinese Academy of Engineering and a researcher at the Institute of Military Medicine under the Academy of Military Sciences, was the first to be approved for clinical trials, said Wu Yuanbin, director-general of science and technology for social development with MOST, at a press conference on Tuesday.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
